Comparing Daratumumab vs Revlimid
| Daratumumab | Revlimid (lenalidomide) |
|
|---|
| Daratumumab | Revlimid (lenalidomide) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Multiple Myeloma. Daratumumab may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Follicular Lymphoma, Anemia, Mantle Cell Lymphoma, Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, Myelodysplastic Diseases. Revlimid may also be used for purposes not listed in... View more |
Related suggestions Multiple Myeloma
|
|||||||
| More about Daratumumab | More about Revlimid (lenalidomide) | ||||||||
| Ratings & Reviews | |||||||||
|
Daratumumab has an average rating of 8.4 out of 10 from a total of 20 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 10% reported a negative effect. |
Revlimid has an average rating of 7.0 out of 10 from a total of 28 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Daratumumab side effects |
View all Revlimid side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Revlimid prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Darzalex |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
432 hours |
3 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 176 drugs are known to interact with Daratumumab:
|
A total of 273 drugs are known to interact with Revlimid:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 16, 2015 |
December 27, 2005 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.